hepg2 human hepatocellular carcinoma cells (ATCC)
Structured Review

Hepg2 Human Hepatocellular Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 31345 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepg2 human hepatocellular carcinoma cells/product/ATCC
Average 99 stars, based on 31345 article reviews
Images
1) Product Images from "Structure‐Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off‐Target Effects"
Article Title: Structure‐Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off‐Target Effects
Journal: Chemmedchem
doi: 10.1002/cmdc.202500960
Figure Legend Snippet: Results of RT‐PCR in HepG2 cell line following overnight treatment with endogenous FXR agonist CDCA ( red ) (30 μM), OCA ( purple ) (10 µM), compound 2 ( green ) (10 μM and 30 μM), or compound 16 ( blue ) (10 μM and 30 μM). Not treated cells ( white ) were stimulated with DMSO 0.1. % Statistical significance was analyzed by One‐way Anova‐GraphPad Prism 5. ns = not significant, *p < 0.05, **p < 0.01, ***p < 0.001 vs 0.1% NT = not treated (DMSO).
Techniques Used: Reverse Transcription Polymerase Chain Reaction

